The WHO-HAEM4R entity of high-grade B-cell lymphoma with dual rearrangements of MYC and BCL2 and/or BCL6 has been conceptually reframed and reassigned. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.